Insider trade

Stryker Corporation (SYK): Group President sold ~$175K

James Andrew Pierce, Group President at Stryker Corporation, sold ~$175K of Stryker Corporation shares.

~$175K
Approx. value · 475 sh @ $368.87
71K
Holds after · shares reported
Traded
Feb 2, 2026
Filed
Feb 3, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 23, 2024CongressDisclosed purchase of SYK — reported range $1,001 - $15,000
  2. Oct 16, 2025CongressDisclosed sale of SYK — reported range $1,001 - $15,000
  3. Nov 18, 2025CongressDisclosed purchase of SYK — reported range $1,001 - $15,000
  4. Nov 20, 2025CongressDisclosed partial sale of SYK — reported range $15,001 - $50,000
  5. Dec 4, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Stryker Corporation (the “Company”) announced on December 4, 2025 that Spencer Stiles, who currently serves as Group President, Orthopaedics, has been appointed President and Chief Operating Officer of the Company effective January 1, 2026.”
  6. Dec 10, 2025CongressDisclosed purchase of SYK — reported range $1,001 - $15,000
  7. Jan 23, 2026CongressDisclosed partial sale of SYK — reported range $15,001 - $50,000
  8. Jan 29, 2026Company filing · Form 8-K · ResultsReported its results
  9. Feb 2, 2026 · this disclosureInsiderOfficer sold ~$175K of SYK shares in the open market

What came next

  1. Feb 4, 2026Insider · 1 personInsiders: 11 sales (~$90.7M)
  2. Feb 5, 2026Insider · 1 personInsiders: 7 sales (~$91.0M)
  3. Feb 11, 20265% stakeGREENLEAF TRUST reported a passive stake (13G) of 4.4%
  4. Feb 24, 2026Federal contract · $990K obligatedDepartment of Veterans Affairs awarded Stryker Corporation: $990K obligated to date
  5. Mar 10, 2026Federal contract · $1.1M obligatedDepartment of Veterans Affairs awarded Stryker Corporation: $1.07M obligated to date
  6. Mar 11, 2026Company filing · Form 8-K · Cyber incident, Reg FDReported a cybersecurity incident, and shared information with investors“As previously disclosed in the Original Report and as further reported on two”
  7. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  8. Apr 10, 2026FDARecall: BARD Dynamic Tip Steerable, Product Number 6DYNTP001;
  9. Apr 10, 2026FDARecall: BARD Dynamic Deca Steerable, Product Number 201101; REPROCESSED ELECTROPHYSIOLOGY CATHETER
  10. Apr 10, 2026FDARecall: Daig Livewire Steerable, Product Number 401904; REPROCESSED ELECTROPHYSIOLOGY CATHETER
  11. Apr 10, 2026FDARecall: BARD EP XT Decapolar Steerable, Product Number 201007; REPROCESSED ELECTROPHYSIOLOGY CATHETER
  12. Apr 10, 2026FDARecall: Daig Livewire Steerable, Product Number 401581; REPROCESSED ELECTROPHYSIOLOGY CATHETER
  13. Apr 10, 2026FDARecall: Daig Livewire Steerable, Product Number 401915; REPROCESSED ELECTROPHYSIOLOGY CATHETER
  14. Apr 10, 2026FDARecall: BARD Dynamic Tip Steerable, Product Number 200344; REPROCESSED ELECTROPHYSIOLOGY CATHETER
  15. Apr 10, 2026FDARecall: Daig Livewire Steerable, Product Number 401905; REPROCESSED ELECTROPHYSIOLOGY CATHETER
  16. Apr 10, 2026FDARecall: Daig Livewire Steerable, Product Number 401582; REPROCESSED ELECTROPHYSIOLOGY CATHETER
  17. Apr 14, 20265% stakeSTRYKER RONDA E filed an activist stake (13D) of 4.0%
  18. Apr 24, 2026FDAFDA device clearance: Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip; Vitoss® BiModal Bioactive Bone Graft Substitute; Vitoss BBTrauma® Bioactive Bone Graft Substitute;…
  19. Apr 30, 2026Company filing · Form 8-K · ResultsReported its results
  20. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.7%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Stryker Corporation

For Stryker Corporation, OQRO holds 33 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SYK page.

How this filing works

Explore the data

Common questions

Which Stryker Corporation (SYK) insider traded, and how much?

James Andrew Pierce, Group President at Stryker Corporation, sold ~$175K of Stryker Corporation shares. 475 shares at $368.87.

When did it happen, and when was it made public?

Traded: Feb 2, 2026. Filed: Feb 3, 2026. That is 1 day between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Stryker Corporation recently?

For Stryker Corporation, OQRO holds 33 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 2 federal contract awards dated in the last 90 days. They are listed on the SYK page.

Does this mean SYK stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Stryker Corporation

Everything OQRO holds on this company is on its SYK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data